Table 3 Antifungal activity of synthesized compound a6
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compound | Zone of inhibition (mm) | |||
|---|---|---|---|---|
Fungal species | ||||
A. ochraceus (AUCC-230) | P. chrysogenum (AUCC-530) | A. fleavus (AUCC-164) | C. albicans (AUCC-1720) | |
a6 | 18 (45%) | 14 (37%) | 16 (42%) | 34 (85%) |
Mycostatine | 40 (100) | 38 (100%) | 38 (100%) | 40 (100%) |